SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-002758
Filing Date
2023-02-17
Accepted
2023-02-17 16:16:19
Documents
1
Period of Report
2023-02-15

Document Format Files

Seq Description Document Type Size
1 form4-02172023_040232.html 4  
1 form4-02172023_040232.xml 4 3995
  Complete submission text file 0001415889-23-002758.txt   5351
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Issuer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNEERING CORPORATION 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address
Hall Brett Matthew (Reporting) CIK: 0001870437 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40675 | Film No.: 23642770